ArticleWorld journal of urology2025
Gross hematuria in nonagenarians admitted to a urological ward: prevalence, predictors, and outcomes.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe the trajectories of nonagenarians admitted to a urological ward and to identify risk factors for admission due to gross hematuria (GH) and its impact on discharge status.
methodsA retrospective cohort study of nonagenarians admitted to a tertiary care center between 2014 and 2022 was conducted. Data on demographics, comorbidities, medication, and outcomes were collected. Frailty was assessed via the Canadian Study of Health and Aging Clinical Frailty Scale (CSHA-CFS). Multivariable Poisson regression was used to assess risk factors for GH-related admissions. Secondary endpoints included changes in discharge status and survival, analyzed using Kaplan-Meier and restricted mean survival time (RMST).
resultsAmong 317 patients (median age 92 yrs [IQR 91-94], 63.7% male), 134 (42.3%) were admitted for hematuria. Antithrombotic therapy (aRR = 1.40, 95% CI 1.02-1.92, p = 0.013) and history of bladder cancer (aRR = 1.46, 95% CI 1.08-1.96, p = 0.013) were significantly associated with hematuria-related admissions. Increased social service utilization was more frequent among hematuria patients (13.4% vs. 8.7%), reaching significance in sensitivity analysis (aRR = 2.17 95%CI 1.16-4.06, p = 0.02). One-year mortality was higher among hematuria patients (34.3% vs. 24.5%), with lower RMST (12 vs. 15 months). In-hospital mortality during the index admission was low across both groups. The CSHA-CFS had limited discriminative power to predict 1-year mortality (AUC = 0.59).
conclusionGH is a common reason for admission in nonagenarians and may indicate broader vulnerability. Geriatric assessment tools could aid in clinical decision-making and discharge planning. Future research should validate frailty-based risk stratification and address functional decline related to hospitalization in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.